<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> has a well-recognized association with oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, with phenotypic progression through <z:mpath ids='MPATH_589'>dysplasia</z:mpath> to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The nuclear phosphoprotein p53 is a putative <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor with mutations resulting in both loss of negative growth regulatory function and possible gain of oncogene function </plain></SENT>
<SENT sid="2" pm="."><plain>Many mutant forms have a prolonged half-life and are demonstrable with immunohistochemical techniques </plain></SENT>
<SENT sid="3" pm="."><plain>We examined 62 endoscopic oesophageal biopsies and 36 oesophageal resections for p53 overexpression using the monoclonal antibody DO-7 on paraffin-embedded tissue </plain></SENT>
<SENT sid="4" pm="."><plain>The series included 40 cases of Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, 13 cases of <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 81 cases of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>None of the cases of <z:mpath ids='MPATH_160'>metaplasia</z:mpath> was p53-positive, compared with 4/13 cases of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 52/81 cases of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>There was no association between the degree of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and p53 expression, although a trend emerged of increasing p53 expression with higher <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that p53 overexpression is frequent in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and may be related to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade </plain></SENT>
<SENT sid="8" pm="."><plain>p53 overexpression is not restricted to neoplastic lesions and mutation of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> suppressor may occur early in the malignant progression of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
</text></document>